Imamura Teruhiko, Nitta Daisuke, Kinugawa Koichiro
Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Second Department of Internal Medicine, Toyama University, 2630 Sugitani Toyama-shi, Toyama, 930-0194, Japan.
BMC Cardiovasc Disord. 2017 Jan 5;17(1):11. doi: 10.1186/s12872-016-0455-4.
Adaptive servo-ventilation (ASV) therapy is a recent non-invasive positive pressure ventilation therapy that was developed for patients with heart failure (HF) refractory to optimal medical therapy. However, it is likely that ASV therapy at relatively higher pressure setting worsens some of the patients' prognosis compared with optimal medical therapy. Therefore, identification of optimal pressure settings of ASV therapy is warranted.
We present the case of a 42-year-old male with HF, which was caused by dilated cardiomyopathy, who was admitted to our institution for evaluating his eligibility for heart transplantation. To identify the optimal pressure setting [peak end-expiratory pressure (PEEP) ramp test], we performed an ASV support test, during which the PEEP settings were set at levels ranging from 4 to 8 mmHg, and a heart rate variability (HRV) analysis using the MemCalc power spectral density method. Clinical parameters varied dramatically during the PEEP ramp test. Over incremental PEEP levels, pulmonary capillary wedge pressure, cardiac index and high-frequency level (reflecting parasympathetic activity) decreased; however, the low-frequency level increased along with increase in plasma noradrenaline concentrations.
An inappropriately high PEEP setting may stimulate sympathetic nerve activity accompanied by decreased cardiac output. This was the first report on the PEEP ramp test during ASV therapy. Further research is warranted to determine whether use of optimal pressure settings using HRV analyses may improve the long-term prognosis of such patients.
适应性伺服通气(ASV)疗法是一种最近开发的无创正压通气疗法,用于对最佳药物治疗无效的心力衰竭(HF)患者。然而,与最佳药物治疗相比,相对较高压力设置的ASV疗法可能会使一些患者的预后恶化。因此,确定ASV疗法的最佳压力设置是必要的。
我们报告一例42岁男性扩张型心肌病所致HF患者,因评估其心脏移植资格入住我院。为确定最佳压力设置[呼气末峰值压力(PEEP)递增试验],我们进行了ASV支持试验,期间PEEP设置在4至8 mmHg范围内,并使用MemCalc功率谱密度法进行心率变异性(HRV)分析。在PEEP递增试验期间,临床参数变化显著。随着PEEP水平逐渐升高,肺毛细血管楔压、心脏指数和高频水平(反映副交感神经活动)降低;然而,低频水平随着血浆去甲肾上腺素浓度的升高而升高。
不适当的高PEEP设置可能刺激交感神经活动并伴有心输出量降低。这是关于ASV治疗期间PEEP递增试验的首份报告。有必要进一步研究以确定使用HRV分析的最佳压力设置是否可改善此类患者的长期预后。